Form 13-F position report

KEZAR LIFE SCIENCES INC

Reported by STATE STREET CORPORATION

Manager portfolio Source filing
KZR CUSIP 49372L100 Manager CIK 0000093751
Latest reported change

Reported 3,537,701 shares, up 2,802,611 (381.3%) from the prior quarter.

Reported value 401.1%; share count 381.3% vs. the prior quarter.

Added
% of reported 13F value < 0.01% This manager · Q3 2022
Shares 3,537,701 Quarter-end amount reported
Reported value $30,460,000 Fair value at quarter end
Consecutive quarters held 17 Through Q3 2022

Reported position value by quarter

Reported position value by quarter

Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.

Manager history

Quarterly position history

How this manager's reported quarter-end position changed over time.

14 quarters
Quarter Activity Shares Change % of reported 13F Reported value Filed
Q4 2024 Reduced 0 -185,941 (-100.0%) 0 $0 2025-02-14
Q3 2024 Unchanged 185,941 0 (0.0%) < 0.01% $143,770 2024-11-14
Q2 2024 Reduced 185,941 -937,833 (-83.5%) < 0.01% $111,565 2024-08-14
Q1 2024 Added 1,123,774 +7,722 (0.7%) < 0.01% $1,013,195 2024-05-15
Q4 2023 Added 1,116,052 +3,492 (0.3%) < 0.01% $1,057,348 2024-02-14
Q3 2023 Added 1,112,560 +16,844 (1.5%) < 0.01% $1,323,946 2023-11-14
Q2 2023 Reduced 1,095,716 -2,143,717 (-66.2%) < 0.01% $2,684,504 2023-08-14
Q1 2023 Reduced 3,239,433 -1,014,527 (-23.8%) < 0.01% $10,139,425 2023-05-15
Q4 2022 Added 4,253,960 +716,259 (20.2%) < 0.01% $29,947,878 2023-02-14
Q3 2022 Added 3,537,701 +2,802,611 (381.3%) < 0.01% $30,460,000 2022-11-15
Q2 2022 Reduced 735,090 -1,507,464 (-67.2%) < 0.01% $6,079,000 2022-08-15
Q1 2022 Added 2,242,554 +902,588 (67.4%) < 0.01% $37,271,000 2022-05-16
Q4 2021 Added 1,339,966 +734,562 (121.3%) < 0.01% $22,404,000 2022-02-14
Q3 2021 Added 605,404 +90,614 (17.6%) < 0.01% $5,231,000 2021-11-15
Five years are shown. A free account unlocks the complete reported history. Unlock full history
Institutional context

Who else reported the position

151 managers reported KEZAR LIFE SCIENCES INC for Q3 2022.

Manager Activity Shares Change % of reported 13F Reported value Tenure
Avidity Partners Management LP Added 5,414,400 +1,364,400 0.95% $46,618,000 7 qtrs
BlackRock Inc Added 4,104,929 +525,139 < 0.01% $35,343,000 18 qtrs
STATE STREET CORPORATION This report Added 3,537,701 +2,802,611 < 0.01% $30,460,000 17 qtrs
SUVRETTA CAPITAL MANAGEMENT LLC Reduced 3,275,520 -1,136,780 1.17% $28,202,000 11 qtrs
Bellevue Group AG Reduced 3,031,000 -4,000 0.37% $26,097,000 14 qtrs
VANGUARD GROUP INC Added 2,993,207 +556,020 < 0.01% $25,771,000 18 qtrs
MILLENNIUM MANAGEMENT LLC Added 2,962,268 +213,322 0.02% $25,505,000 14 qtrs
VICTORY CAPITAL MANAGEMENT INC Reduced 2,359,492 -410,606 0.02% $20,315,000 18 qtrs
ORBIMED ADVISORS LLC Added 1,771,700 +351,800 0.29% $15,254,000 2 qtrs
CHI Advisors LLC Reduced 1,762,793 -78,000 4.08% $15,178,000 13 qtrs
A free account expands this comparison to 25 managers. Create free account
Premium adds each manager's conviction percentile across reporting peers.
Filing details and methodology As reported
Report period
September 30, 2022
Filed
November 15, 2022
Filing type
13F-HR
Position type
COM

Voting authority reported

Sole
3,477,101
Shared
0
None
60,600

“None” means the manager reported no voting authority for those shares on non-routine matters. It does not disclose why and is not evidence of securities lending.

Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.